2008
DOI: 10.1007/s12311-008-0005-4
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological characterization and anatomical distribution of the dopamine transporter in the mouse cerebellum

Abstract: We studied the binding parameters, the pharmacological profile and the anatomical distribution of the dopamine transporter in the mouse cerebellum by using the specific dopamine uptake antagonist [(3)H]GBR12935 and an antidopamine transporter monoclonal antibody. Competition experiments in cerebellar and striatal membrane preparations showed that [(3)H]GBR12935 binds to a specific binding site, sensitive to dopamine and low concentrations of mazindol. The affinity of dopamine for the cerebellar binding site wa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
10
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 35 publications
2
10
0
Order By: Relevance
“…In rats, VTA sends glutamatergic projections to LCN, but not dopaminergic projections(13). All cerebellar nuclei are reported to have DAT-like binding, which is not blocked by norepinephrine(46, 82). Other possible sources of catecholamines in the LCN include a small population of Purkinje cells in the caudal cerebellum(83); the Zona incerta (catecholamine group A13), which has projections to the interposed cerebellar nuclei(84); and the locus ceruleus, which has been previously shown to release dopamine in the hippocampus, an area with less dopamine than cerebellar nuclei(49, 85–88).…”
Section: Discussionmentioning
confidence: 99%
“…In rats, VTA sends glutamatergic projections to LCN, but not dopaminergic projections(13). All cerebellar nuclei are reported to have DAT-like binding, which is not blocked by norepinephrine(46, 82). Other possible sources of catecholamines in the LCN include a small population of Purkinje cells in the caudal cerebellum(83); the Zona incerta (catecholamine group A13), which has projections to the interposed cerebellar nuclei(84); and the locus ceruleus, which has been previously shown to release dopamine in the hippocampus, an area with less dopamine than cerebellar nuclei(49, 85–88).…”
Section: Discussionmentioning
confidence: 99%
“…Drd2 has been associated with addiction to opioids, nicotine, and cocaine [57] and mRNA encoding for Drd2 increase in response to cocaine treatment [58]. Studies of cerebellum in mice administered cocaine determined dysregulation in cerebral regions that have dopamine-signaling proteins [6, 59, 60]. In mice lacking D2 receptors, the rewarding properties of morphine were reduced [61].…”
Section: Resultsmentioning
confidence: 99%
“…Chemical neuroanatomy studies on the detection of dopaminergic neuronal elements in the cerebellum of mammals (including human) makes use of direct antisera against DA and of [ 3 H]-dopaminergic ligands (Panagopoulos et al, 1991;Panagopoulos and Matsokis, 1994) or antisera against the specific dopaminergic marker, the dopamine transporter (DAT), the plasma membrane monoamine transporter involved in DA synaptic reuptake (Table 1; Melchitzky and Lewis, 2000;Dunnet et al, 2005;Giompres and Delis, 2005;Delis et al, 2008;Kim et al, 2009;Flace et al, 2019bFlace et al, , 2020, the indirect marker of the dopaminergic neurotransmission, the dopamine and adenosine 3 ′ -5 ′ -monophosphate (cAMP)-regulated protein Mr 32,0000 (DARPP-32), a protein phosphatase-1 inhibitor involved in dopaminergic neuronal synaptic signaling (Table 1; Alder and Barbas, 1995;López et al, 2010;Nishi and Shuto, 2017), or, indirectly, by means of antisera against not elective markers for DA, such as tyrosine hydroxylase (TH), the rate-limiting enzyme DA biosynthesis, which catalyzes the conversion of L-tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA) (Table 1; Ikai et al, 1992;Fujii et al, 1994;Melchitzky and Lewis, 2000;White and Thomas, 2012) and vesicular monoamine transporter 2 (VMAT 2 ), the synaptic vesicles transporter of monoamine neurotransmitters such as DA, NA, 5-HT, and histamine (HIS) (Table 1; Kim et al, 2009;Lawal and Krantz, 2013).…”
Section: Morphological Aspects Of the Dopaminergic Cerebellar Systemmentioning
confidence: 99%